Acute Intermittent Porphyria Market SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024 - 2031)

Acute Intermittent Porphyria Market is segmented By Treatment (RNA Interference-based Therapy, Givosiran, Symptomatic Treatment), By Distribution Chan....

Acute Intermittent Porphyria Market Leaders

  • Alnylam Pharmaceuticals
  • Recordati Rare Diseases
  • Mitsubishi Tanabe Pharma
  • Dicerna Pharmaceuticals
  • Moderna
*Disclaimer: Major players are listed in no particular order.

Acute Intermittent Porphyria Market - Company List

  • Alnylam Pharmaceuticals
  • Recordati Rare Diseases
  • Mitsubishi Tanabe Pharma
  • Dicerna Pharmaceuticals
  • Moderna